The effect of ATG on cytokine and cytotoxic T-lymphocyte gene expression in renal allograft recipients during the early post-transplant period

Clinical Transplantation

Volumn 17, Issue 3, 2003, Pages 217-224

  Simon, Tania ^a   Opelz, Gerhard ^a   Weimer, Rolf ^b   Wiesel, Manfred ^a   Feustel, Andreas ^b   Ott, Ralf C ^a   Süsal, Caner ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

ATG; Cytokines; Renal allograft recipients; Serial gene expression; TaqMan real time PCR

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOSPORIN; CYTOKINE; FAS LIGAND; GAMMA INTERFERON; GRANZYME B; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 7; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PERFORIN; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG EFFECT; DRUG MECHANISM; FEMALE; GENE EXPRESSION; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LONG TERM CARE; MALE; NEPHROTOXICITY; POLYMERASE CHAIN REACTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECIPIENT;

ADULT; ANTILYMPHOCYTE SERUM; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; GENE EXPRESSION; HUMANS; KIDNEY TRANSPLANTATION; MALE; POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0038678032     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0012.2003.00031.x     Document Type: Article

References (28)

1. Barry JM. Immunosuppressive drugs in renal transplantation. A review of the regimens. Drugs 1992: 44: 554.
2. Szczech LA, Feldman HI. Effect of anti-lymphocyte antibody induction therapy on renal allograft survival. Transplant Proc 1999: 31: 9S.
3. Djamali A, Turc-Baron C, Portales P et al. Low dose antithymocyte globulins in renal transplantation: daily versus intermittent administration based on T-cell monitoring. Transplantation 2000: 69: 799.
4. Préville X, Flacher M, LeMauff B et al. Mechanisms involved in antithymocyte globulin immunosuppressive activity in a nonhuman primate model. Transplantation 2001: 71: 460.
5. Bonnefoy-Berard N, Revillard JP. Mechanisms of immunosuppression induced by antithymocyte globulins and OKT3. J Heart Lung Transplant 1996: 15: 435.
6. Vasconcellos LM, Schachter AD, Zheng XX et al. Cytotoxic lymphocyte gene expression in peripheral blood leukocytes correlates with rejecting renal allografts. Transplantation 1998: 66: 562.
7. Steinmuller D. Which T cells mediate allograft rejection. Transplantation 1985: 40: 229.
8. Hall BM. Cells mediating allograft rejection. Transplantation 1991: 51: 1141.
9. Sankaran D, Asderakis A, Hutchinson IV et al. Cytokine gene polymorphisms predict acute graft rejection following renal transplantation. Kidney Int 1999: 56: 281.
10. Asderakis A, Sankaran D, Dyer P et al. Association of polymorphisms in the human interferon-γ and interleukin-10 gene with acute and chronic kidney transplant outcome. Transplantation 2001: 71: 674.
11. de Mattos AM, Meyer MM, Norman DJ, Bennett WM, Sprague J, Bakke AC. Interleukin-12 p40 m-RNA expression in human kidney allograft biopsies. Transpl Immunol 1997: 5: 199.
12. Baan CC, Boelaars-van Haperen MJAM, van Riemsdijk IC, van der Plas AJ, Weimar W. IL-7 and IL-15 bypass the immunosuppressive action of anti-CD25 monoclonal antibodies. Transplant Proc 2001: 33: 2244.
13. Eikmans M, Sijpkens YWJ, Baelde HJ, de Heer E, Leendert PC, Bruijn JA. High transforming growth factor-β and extracellular matrix mRNA response in renal allografts during early acute rejection is associated with absence of chronic rejection. Transplantation 2002: 73: 573.
14. Nickerson P, Steurer W, Steiger J et al. Cytokines and the Th1/Th2 paradigm in transplantation. Curr Opin Immunol 1994: 6: 757.
15. Livak K. Relative Quantitation of Gene Expression: ABI PRISM 7700 Sequence Detection System: User Bulletin #2. Foster City, CA: Applied Biosystems, 1997.
16. Furukawa Y, Becker G, Stinn JL, Shimizu K, Libby P, Mitchell RN. Interleukin-10 (IL-10) augments allograft arterial disease: paradoxical effects of IL-10 in vivo. Am J Pathol 1999: 155: 1929.
17. Qian S, Li W, Li Y et al. Systemic administration of cellular interleukin-10 can exacerbate cardiac allograft rejection in mice. Transplantation 1996: 62: 1709.
18. Zheng XX, Steele AW, Nickerson PW, Steurer W, Steiger J, Strom TB. Administration of noncytolytic IL-10/Fc in murine models of lipopolysaccharide-induced septic shock and allogeneic islet transplantation. J Immunol 1995: 154: 5590.
19. Lee MS, Wogensen L, Shizuru J, Oldstone MB, Sarvetnick N. Pancreatic islet production of murine interleukin-10 does not inhibit immune-mediated tissue destruction. J Clin Invest 1994: 93: 1332.
20. Li W, Fu F, Lu L et al. Systemic administration of anti-interleukin-10 antibody prolongs organ allograft survival in normal and presensitized recipients. Transplantation 1998: 66: 1587.
21. Weimer R, Zipperle S, Daniel V, Carl S, Opelz G. Pretransplant CD4+ helper function and IL-10 response predict risk of acute kidney graft rejection. Transplantation 1996: 62: 1606.
22. Raafat R, Travis LB, Kalia A, Diven S. Role of transplant induction therapy on recurrence rate of focal segmental glomerulosclerosis. Pedriatr Nephrol 2000: 14: 189.
23. Almond PS, Matas A, Gillingham K et al. Risk factors for chronic rejection in renal allograft recipients. Transplantation 1993: 55: 752.
24. Cheshire JL, Baldwin AS Jr. Synergistic activation of NF-kappaB by tumor necrosis factor alpha and gamma interferon via enhanced I kappaB alpha degradation and de novo I kappaBbeta degradation. Mol Cell Biol 1997: 17: 6746.
25. Tracey KJ, Cerami A. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu Rev Med 1994: 45: 491.
26. Tocci MJ, Matkovich DA, Collier KA et al. The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes. J Immunol 1989: 143: 718.
27. Steiger J, Nickerson PW, Steurer W, Moscovitch-Lopatin M, Strom TB. IL-2 knockout recipient mice reject islet cell allografts. J Immunol 1995: 155: 489.
28. Dai Z, Konieczny BT, Baddoura FK, Lakkis FG. Impaired alloantigen-mediated T cell apoptosis and failure to induce long-term allograft survival in IL-2-deficient mice. J Immunol 1998: 161: 1659.